<!DOCTYPE html>
<html>
<head>	
	<title>Heasley Lab</title>
	<meta name="viewport" content="width=device-width, initial-scale=1.0">
<link rel="stylesheet" href="css/style.css">
</head>
	
<body>
	
<div class="topnav" id="myTopnav">
  <a href="index.html">Home</a>
  <a href="projects.html">Projects</a>
  <a class="active" href="publications.html">Publications</a>
  <a href="contact.html">Contact</a>	
  <div class="dropdown">
	<button class="dropbtn">More</button>
	<div class="dropdown-content">
		<a href="members.html">Members</a>
		<a href="methods/methods.html">Methods</a>
		<a href="methods/reagents.html">Reagents</a>
	</div>
  </div>
</div>

<div class="pubbox">	
<h1>Publications</h1>
	<li><a>Linking tyrosine kinase inhibitor-mediated inflammation with normal 
		epithelial cell homeostasis and tumor therapeutic responses (2018). Gurule NJ and Heasley LE. 
		Cancer Drug Res. In press.</a></li>
	
	<li><a>Altered cell-cycle control, inflammation and adhesion in high-risk persistent bronchial dysplasia. (2018) 
		Merrick DT, Edwards MG, Franklin WA, Sugita M, Keith RL, Miller YE, Friedman MB, Dwyer-Nield LD, 
		Tennis MA, O'Keefe MC, Donald EJ, Malloy JM, van Bokhoven A, Wilson S, Koch PJ, O'Shea C, Coldren C,
		Orlicky DJ, Lu X, Baron AE, Hickey G, Kennedy TC, Powell R, Heasley L, Bunn PA, Geraci M, Nemenoff RA.
		Cancer Res. In press. PMID: 29997230</a></li>
	
	<li><a>Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers. 
		(2018). Bhatia S, Sharma J, Bukkapatnam S, Oweida A, Lennon S, Phan A, Milner D, Uyanga N, Jimeno A, Raben D, 
		Somerset H, Heasley L, Karam SD. Clin Cancer Res. In press. PMID: 29848571</a></li>
	
	<li><a>Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase 
		inhibitors and inherent therapeutic vulnerabilities (2018). Kleczko EK, Heasley LE. 
		Mol Cancer. 17(1):60. PMID: 29458371 PMCID: PMC5817864</a></li>
	
	<li><a>ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer (2018). 
		Pilling AB, Kim J, Estrada-Bernal A, Zhou Q, Le AT, Singleton KR, Heasley LE, Tan AC, DeGregori J, Doebele RC. 
		Oncotarget. 9(10):8823-8835. PMID: 29507657 PMCID: PMC5823650</a></li>
	
	<li><a>The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade (2017). 
		Li HY, McSharry M, Bullock B, Nguyen TT, Kwak J, Poczobutt JM, Sippel TR, Heasley LE, Weiser-Evans MC, 
		Clambey ET, Nemenoff RA. Cancer Immunol Res. 5(9):767-777. PMID: 28819064 PMCID: PMC5787226</a></li>
	
	<li><a>Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and 
		neck squamous cell carcinoma (2017). Oweida A, Lennon S, Calame D, Korpela S, Bhatia S, Sharma J, Graham C, 
		Binder D, Serkova N, Raben D, Heasley L, Clambey E, Nemenoff R, Karam SD. 
		Oncoimmunology. 6(10):e1356153. PMID: 29123967 PMCID: PMC5665079</a></li>
	
	<li><a>Co-dependency of PKCδ and K-Ras: inverse association with cytotoxic drug sensitivity in 
		KRAS mutant lung cancer (2017). Ohm AM, Tan AC, Heasley LE, Reyland ME. 
		Oncogene. 36(30):4370-4378. PMID: 28368426 PMCID: PMC5532068</a></li>
	
	<li><a>EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases (2017). 
		Vaishnavi A, Schubert L, Rix U, Marek LA, Le AT, Keysar SB, Glogowska MJ, Smith MA, Kako S, 
		Sumi NJ, Davies KD, Ware KE, Varella-Garcia M, Haura EB, Jimeno A, Heasley LE, Aisner DL, Doebele RC. 
		Cancer Res. 77(13):3551-3563. PMID: 28428274 PMCID: PMC5516930</a></li>
	
	<li><a>Analysis of Drug Resistance Using Kinome-Wide Functional Screens (2017). 
		Singleton KR, Earley KT, Heasley LE. 
		Methods in Molec Biol (Clifton, N.J.). 1636:163-177. PMID: 28730479</a></li>
	
	<li><a>Identifying kinase dependency in cancer cells by integrating high-throughput drug screening 
		and kinase inhibition data (2015). Ryall KA, Shin J, Yoo M, Hinz TK, Kim J, Kang J, Heasley LE, Tan AC.
		Bioinformatics. 2015; 31(23):3799-806.PMID: 26206305 PMCID: PMC4675831</a></li>
	
	<li><a>Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for 
		Treatment of Lung Cancer and HNSCC (2015). Singleton KR, Hinz TK, Kleczko EK, Marek LA, Kwak J, 
		Harp T, Kim J, Tan AC, Heasley LE.  Cancer Res. 2015; 75(20):4398-406. NIHMSID: NIHMS718410</a></li>
	
	<li><a>FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers (2015). 
		Göke F, Franzen A, Hinz TK, Marek LA, Yoon P, Sharma R, Bode M, von Maessenhausen A, Lankat-Buttgereit B, 
		Göke A, Golletz C, Kirsten R, Boehm D, Vogel W, Kleczko EK, Eagles JR, Hirsch FR, Van Bremen T, Bootz F, 
		Schroeck A, Kim J, Tan AC, Jimeno A, Heasley LE, Perner S. 
		Clin Can Res 21(19):4356-64. PMID: 26015511 PMCID: PMC4592392</a></li>
		
		
	
	<li><a href="http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0014117&type=printable" target="_blank">
		Rapidly Acquired Resistance to EGFR Tyrosine Kinase
		Inhibitors in NSCLC Cell Lines through De-Repression of
		FGFR2 and FGFR3 Expression</a></li>
	
	<li><a href="https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.1840220440" target="_blank">Membrane-
		Spanning Receptors or Phorbol Esters Activate
		Mitogen-Activated Protein Kinase in Rat Hepatocytes</a></li>
	
	<li><a href="https://watermark.silverchair.com/bgu094.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfK
		Ac485ysgAAAbswggG3BgkqhkiG9w0BBwagggGoMIIBpAIBADCCAZ0GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMl3j-RorH
		vzMBFf3cAgEQgIIBbl2NNBz-6Qa6k0ewcE7m1aeJkgWabbA3FRalifY5lleI6rXRkU3g3JSU-PseoRCNilJ0UtsGRhDHv8xcf5
		XuyJPfqKcvFhL65SHu-tUut5jS_vOpKWqWwc6D1vn-4yRv2uy5b34uuCXSMsHV53sYT_sjwj_rptssJUX4RTeloIMRnRAYL6IS
		y-WE505G3uITLJQMnJG8ud3TtQ9CazCf7Do4v0Qc1MPTxszlflsLhBK9PvDV6SlTNWncq_aFYqTHaKeUW-KmSyyRDAKyyHFgxR
		iKbU0R2mcA50zSkIQ9fQdSYzE_Q-DrpXezItbTPO6gV8alxAGRDWj0dlV_ErXw_4CQD6ZjoUNDxBqlD9aBvS_AWbTKueVqr5O6
		KAo65grpifV45bBGsIZZvb1O8lHEzNyQSfKY-jlKPYgIF_aGbIPAFocFyKPFju-11J4NCtjE2GNmpDEpaBRB6SCpSSbRS13ucH
		yzFPZTd1VyS55K_g" target="_blank">Expression and role of the embryonic protein SOX2 in head and neck squamous cell
		carcinoma</a></li>
	
	<li><a href="http://mcr.aacrjournals.org/content/molcanres/12/10/1460.full.pdf" target="_blank">Nonamplified FGFR1 Is a Growth 
		Driver in Malignant Pleural
		Mesothelioma</a></li>
	
	
</div>
	<div class="footer"><a href="publications.html">Back to top</a></div>
<script>
window.onscroll = function() {navLock()};
var navbar = document.getElementById("myTopnav");
var sticky = navbar.offsetTop;
function navLock() {
  if (window.pageYOffset >= sticky) {
    navbar.classList.add("sticky")
  } else {
    navbar.classList.remove("sticky");
  }
}
</script>
	
</body>
</html>
